BioCorRx (BICX) Gross Margin (2011 - 2026)
BioCorRx (BICX) reported Gross Margin of 88.26% for Q1 2026, down 11.74 percentage points from 100.00% a year earlier.
Powered by 
Analysis
BioCorRx (BICX) Gross Margin (2011 - 2026) Analysis & Trends
Over the twelve months ended Mar 31, 2026, BioCorRx's Gross Margin came in at 36.98%, down 63.02 percentage points year-over-year; for FY2024, it came in at 78.25%, up 18.61 percentage points from FY2023.
- Gross Margin has a five-year change of +12.24 percentage points (FY2019 to FY2024).
- By year, Gross Margin came in at 59.64% in FY2023 (-33.22 pp), 92.85% in FY2022 (+5.04 pp), 87.82% in FY2021 (+66.06 pp) and 21.75% in FY2020 (-44.26 pp).
- The Q1 2026 figure ranks as the lowest quarterly Gross Margin since Q1 2024.
- The high point for year-over-year Gross Margin in five years was Q4 2021 (a gain of 112.44 percentage points); the low point was Q4 2023 (a drop of 58.46 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,132.46 Bn | 1,101.04 Bn | 19.71 Bn | 85.78% |
| 2 | Johnson & Johnson | 614.45 Bn | 532.98 Bn | 17.26 Bn | 68.19% |
| 3 | AbbVie | 503.76 Bn | 476.87 Bn | 12.70 Bn | 74.74% |
| 4 | Merck | 367.67 Bn | 322.05 Bn | 12.21 Bn | 73.54% |
| 5 | Novartis Ag | 298.09 Bn | 262.08 Bn | 11.24 Bn | 78.02% |
| 6 | Astrazeneca | 261.81 Bn | 235.50 Bn | 12.86 Bn | 83.60% |
| 7 | Amgen | 236.49 Bn | 191.89 Bn | 7.24 Bn | 72.04% |
| 8 | Gilead Sciences | 191.25 Bn | 165.45 Bn | 6.22 Bn | 79.76% |
| 9 | Pfizer | 170.18 Bn | 116.83 Bn | 10.94 Bn | 72.78% |
| 10 | BioCorRx | 4.32 Mn | 3.66 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 88.26% |
| Mar 31, 2025 | 100.00% |
| Jun 30, 2024 | 100.00% |
| Mar 31, 2024 | 53.95% |
| Dec 31, 2023 | 31.08% |
| Sep 30, 2023 | 61.74% |
| Jun 30, 2023 | 47.16% |
| Mar 31, 2023 | 78.55% |
| Dec 31, 2022 | 89.53% |
| Sep 30, 2022 | 97.52% |
| Jun 30, 2022 | 82.97% |
| Mar 31, 2022 | 92.52% |
| Jun 30, 2020 | 18.36% |
| Mar 31, 2020 | 37.84% |
| Dec 31, 2019 | 58.06% |
| Sep 30, 2019 | 52.12% |
| Jun 30, 2019 | 53.98% |
| Mar 31, 2019 | 95.68% |
| Dec 31, 2018 | -24.96% |
| Sep 30, 2018 | 73.81% |
API Access
BioCorRx Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=BICX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "BICX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=BICX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();